Currently out of the existing stock ratings of Cecilia Furlong, 106 are a HOLD (50.96%), 93 are a BUY (44.71%), 9 are a SELL (4.33%).

Cecilia Furlong

Work Performance Price Targets & Ratings Chart

Analyst Cecilia Furlong, currently employed carries an average stock price target met ratio of 54.28% that have a potential upside of 16.71% achieved within 145 days. Previously, Cecilia Furlong worked at MORGAN STANLEY.

Cecilia Furlong’s has documented 407 price targets and ratings displayed on 29 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZBH, Zimmer Biomet Holdings at 15-Jul-2024.

Wall Street Analyst Cecilia Furlong

Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for IRTC (IRHYTHM TECHNOLOGIES) at 1/7/2022. The price target of $129 was fulfilled within 3 days with a profit of $27.05 (26.53%) receiving and performance score of 88.44.

Average potential price target upside

of $39.06 (17.22%) on SYK (STRYKER).
of $35.73 (13.89%) on PODD (INSULET).
of $26.43 (31.13%) on IRTC (IRHYTHM TECHNOLOGIES).

ABT Abbott Laboratories ALC Alcon AG CRY CryoLife EW Edwards Lifesciences Corp SGHT Sight Sciences SWAV Shockwave Medical TMDX TransMedics Group VAPO Vapotherm BSX Boston Scientific Corp LUNG Pulmonx Corp BAX Baxter International DXCM DexCom IRTC iRhythm Technologies ISRG Intuitive Surgical NVRO Nevro Corp AORT Artivion BLCO Bausch + Lomb Corp EMBC Embecta Corp TFX Teleflex orporated VRAY ViewRay MDT Medtronic PLC NARI Inari Medical SYK Stryker ZBH Zimmer Biomet Holdings ABMD ABIOMED ATRC AtriCure AXNX Axonics Modulation Technologies PODD Insulet IRT Independence Realty Trust

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Matt Miksic (BARCLAYS)